CochLear (OTCMKTS:CHEOY) Stock Price Down 0.1% – Here’s What Happened

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) traded down 0.1% during trading on Tuesday . The company traded as low as $94.14 and last traded at $94.18. 5,277 shares changed hands during trading, a decline of 16% from the average session volume of 6,295 shares. The stock had previously closed at $94.25.

Wall Street Analyst Weigh In

CHEOY has been the subject of a number of recent analyst reports. Zacks Research upgraded shares of CochLear to a “hold” rating in a report on Monday, August 11th. UBS Group raised CochLear from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, June 18th. Finally, Citigroup lowered CochLear to a “neutral” rating in a research report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, CochLear presently has a consensus rating of “Moderate Buy”.

View Our Latest Report on CHEOY

CochLear Stock Down 0.1%

The company has a 50-day moving average price of $98.10 and a two-hundred day moving average price of $92.53.

CochLear Dividend Announcement

The business also recently announced a dividend, which will be paid on Tuesday, October 28th. Investors of record on Monday, September 22nd will be issued a dividend of $0.1045 per share. This represents a dividend yield of 122.0%. The ex-dividend date is Friday, September 19th.

CochLear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Recommended Stories

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.